We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mathematical Model Improves Radiation Therapy

By HospiMedica International staff writers
Posted on 19 Sep 2019
A new mathematical model spatially optimizes external beam radiation therapy (XRT) in order to significantly increase the number of brain tumor cells killed during treatment.

Developed at the University of Waterloo (UW; Canada) and the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), the new model optimizes one-step and two-step radiation profiles during the first and second XRT fractions, while setting a cap on the total dose a patient could receive throughout treatment. More...
Tumor anatomy was then sectioned into multiple portions, with the area most densely populated with cells being one portion and the remainder of cells the other.

In some instances, they prescribed the dosage of radiation given to each portion, and in other cases, they allowed the model to determine the best ratio. The results suggested that spatial optimization requires imaging the tumor twice, determining the dose and treatment schedule, and optimizing the first radiation fraction using the model. Using the growth model deduced from the initial two images, oncologists can then use the derived cell density profile prior to each instance of XRT as input to optimize the shape of the radiation beam. The study was published on June 28, 2019, in PLOS One.

“Typically, cells in a tumor are packed at a higher density in the middle and less as you go further out, but that fact is not fully taken into account in current radiation treatment,” said lead author PhD candidate Cameron Meaney, MSc, of the Waterloo Department of Applied Mathematics. “What our model has shown is that perhaps what's best is if we take the total radiation dose that we're allowed to give a patient and administer it over a small area at high strength where the cells are most dense, instead of spreading it over a big area with semi-weak strength.”

Glioblastomas are the most aggressive, and unfortunately most common, form of primary brain tumor. They are characterized by rapid growth and invasiveness, yielding survival times that seldom exceed a year. As a result, treatments for glioblastomas are swift and aggressive, usually involving a combination of surgical intervention, chemotherapy, and XRT, with postoperative chemotherapy and XRT a crucial part of effective treatments.

Related Links:
University of Waterloo
Massachusetts Institute of Technology


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: 123RF

AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection

Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.